Evrima Technologies
PrivateLast Round
Seed
Sep 5, 2022
Total Funding Raised
$2.08M
Company Overview
Evrima Technologies is a healthcare technology company that provides an end-to-end clinical trial recruitment and management platform to streamline patient identification and trial processes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS, Marketing
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evrima Technologies Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Evrima Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 5, 2022 |
Evrima Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BridgeLane Capital | Seed |
| Artesian | Seed |
| Wavemaker Partners | Seed |
Evrima Technologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evrima Technologies's valuation, stock price, and market status.